Arvinas (ARVN) Current Deferred Revenue (2017 - 2026)

Arvinas' (ARVN) quarterly Current Deferred Revenue came in at $51.8 million in Q1 2026, down 80.03% year-on-year from $259.4 million in Q1 2025, and down 74.81% quarter-over-quarter from $205.6 million in Q4 2025.

Arvinas (ARVN) Current Deferred Revenue (2017 - 2026) Analysis & Trends

Arvinas' Current Deferred Revenue history runs 10 years deep, the most recent figure standing at $51.8 million for Q1 2026.

  • On a quarterly basis, Current Deferred Revenue fell 80.03% year-over-year to $51.8 million in Q1 2026; TTM through Mar 2026 was $51.8 million, a 80.03% decrease from a year earlier, with the FY2025 full-year figure at $205.6 million, down 54.13% from the prior year.
  • Current Deferred Revenue eased to $51.8 million in Q1 2026 per ARVN's latest filing, from $205.6 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $719.4 million in Q1 2022 and bottomed at $51.8 million in Q1 2026.
  • The 5-year median for Current Deferred Revenue is $523.9 million (2024), against an average of $458.1 million.
  • Across the five-year window, Current Deferred Revenue surged 1759.46% in 2022 and slumped 82.83% in 2025, its largest moves.
  • Year by year, Current Deferred Revenue stood at $623.7 million in 2022, then fell by 11.94% to $549.2 million in 2023, then retreated by 18.39% to $448.2 million in 2024, then tumbled by 54.13% to $205.6 million in 2025, then plunged by 74.81% to $51.8 million in 2026.
  • Per Business Quant, the three latest ARVN Current Deferred Revenue figures stand at $51.8 million (Q1 2026), $205.6 million (Q4 2025), and $215.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Arvinas 519.68 Mn -95.22 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 51.80 Mn
Dec 31, 2025 205.60 Mn
Sep 30, 2025 215.10 Mn
Jun 30, 2025 102.90 Mn
Mar 31, 2025 259.40 Mn
Dec 31, 2024 448.20 Mn
Sep 30, 2024 503.70 Mn
Jun 30, 2024 599.20 Mn
Mar 31, 2024 523.90 Mn
Dec 31, 2023 549.20 Mn
Sep 30, 2023 506.10 Mn
Jun 30, 2023 540.60 Mn
Mar 31, 2023 593.80 Mn
Dec 31, 2022 623.70 Mn
Sep 30, 2022 657.70 Mn
Jun 30, 2022 688.00 Mn
Mar 31, 2022 719.40 Mn
Dec 31, 2021 740.50 Mn
Sep 30, 2021 763.40 Mn
Jun 30, 2021 37.00 Mn